Other Ingredients: Diluent (Maltodextrin and Lactose), Ferric Pyrophosphate, Bulking agent [INS 460 (i)], L-Ascorbic Acid, Disintegrant, Binder, Disintegrant (Sodium Starch Glycolate), Coating Agent (INS 464), Sodium chloride, Vehicle (Polyethylene Glycol 6000), Anticaking agent (INS 551), Antisticking Agent [INS 470 (iii)], Colour, Vehicle (Polyethene Glycol 4000), Glidant, Coating Agent (INS 462), Colour (INS 171), N- N-pteroyl-I-glutamic acid and Emulsifier
As an obesity and lipid specialist physician, Ive seen how drugs like Ozempic, Wegovy, and their predecessors have completely changed the landscape for people struggling with type-2 diabetes and obesity
Consistent with the non-glycaemic effects of glucagon to inhibit food intake, enhance lipid metabolism and accelerate energy expenditure [70], a single-molecule GLP-1/GCGR co-agonist improved body weight and glucose control in mice with DIO beyond that observed with GLP-1 receptor agonism alone [114, 115]
GLOW Blend would actually confound the results
Australas J Dermatol (2021) 62:e8891
Thyroid tumors have been reported in rodents given GLP analogs and thyroid C-cell hyperplasia has been reported in humans